A case of type 2 diabetes mellitus with weight gain and worsening of glycemic management after tezepelumab administration for severe bronchial asthma
Abstract Some cases of bronchial asthma are refractory to conventional therapies. As the pathogenesis of bronchial asthma has been clarified, new treatments, such as bronchial thermoplasty and biological drugs, have been developed. Tezepelumab, an anti‐thymic stromal lymphopoietin antibody, has been...
Những tác giả chính: | Kotaro Umamoto, Ryotaro Bouchi, Noriko Ihana‐Sugiyama, Noriko Kodani, Mitsuru Ohsugi, Masayuki Hojo, Kohjiro Ueki, Hiroshi Kajio |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
Wiley
2024-03-01
|
Loạt: | Journal of Diabetes Investigation |
Những chủ đề: | |
Truy cập trực tuyến: | https://doi.org/10.1111/jdi.14127 |
Những quyển sách tương tự
-
Tezepelumab for asthma with current or previous smoking habit: Case series
Bằng: Yoshiro Kai, MD, PhD, et al.
Được phát hành: (2025-05-01) -
Efficacy of tezepelumab against uncontrolled severe non‐type 2 asthma refractory to bronchial thermoplasty, benralizumab, dupilumab and mepolizumab
Bằng: Yoshiro Kai, et al.
Được phát hành: (2024-03-01) -
Tezepelumab for refractory eosinophilic granulomatosis with polyangiitis-related asthma
Bằng: Nina Vincent-Galtié, et al.
Được phát hành: (2024-07-01) -
Three-dimensional bronchial tree visualization in exercise-induced severe asthma following tezepelumab treatment
Bằng: Yoshiro Kai, MD, PhD, et al.
Được phát hành: (2025-05-01) -
Tezepelumab for severe asthma: elevating current practice to recognize epithelial driven profiles
Bằng: Marco Caminati, et al.
Được phát hành: (2024-10-01)